Bocunebart's PACAP-targeting mechanism positions it as a potential first-in-class therapy in a thin pipeline of novel ...
Dr. Monty Pal introduces the program by outlining the evolving treatment landscape for advanced renal cell carcinoma (RCC) ...
LivaNova’s proprietary PolySync algorithm allows for proximal hypoglossal nerve stimulation (p-HGNS) stimulation fields to be ...
Overview: Artificial intelligence allows algorithms to learn patterns and make smart decisions without fixed ...
– Presentation at SLEEP 2026 illustrates ability to convert non-responders into responders using personalized programming ...
LIVN's PolySync data show an 84.5% AHI response rate in OSA patients, building on OSPREY results for its aura6000 System.
9don MSN
Quantum-inspired AI could tailor patients' cancer treatment to their entire molecular background
For a child diagnosed with neuroblastoma—the most common infant cancer, occurring when early nerve cells grow out of ...
Regulatory veterinarians once relied largely on observation and experience. Today, they also walk onto the backstretch with a ...
First and only melanoma gene expression profiling test that is both: Designated as an FDA Breakthrough Device and included in the NCCN guidelines for T1b and T2a cutaneous ...
The Ann Arbor District Library's sixth annual Big Gay Read is diving into "Bury Your Gays," a darkly funny horror novel by masked author Chuck Tingle that somehow predicted the exact AI controversy ...
Health systems preparing Medicare GLP-1 Bridge program focus on staff education, prior authorization, and workflow coordination ahead of July 1 launch.
A systematic program designed to close the diagnosis and treatment gaps for patients with aortic stenosis (AS) seems to be on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results